Table 1 Baseline patient characteristics
Variable | Patients |
|---|---|
Total | 16 |
Male | 11 |
Female | 5 |
Age | 63 (range 50 – 73) |
Performance status | |
0 | 8 |
1 | 8 |
Location of primary lesion | |
Head/Neck | 8 |
Body/Tail | 8 |
Prior (concurrent) chemotherapy | |
Gemcitabine based | 8 |
5-FU based | 5 |
Both | 3 |
Prior treatment | |
Pancreaticoduodenectomy | 1 |
SBRT | 5 |
DEBIRI-TACE | 1 |
Other | 2 |
Median Total Bilirubin | 0.6 (range 0.2 – 2.6) |
Median Albumin | 3.5 (range 2.2 – 4.4) |
Median CA 19-9 | 15,836 (range 2 – 76587) |
Hepatic tumor burden | |
<25 % | 13 |
25-50 % | 3 |
Extra-hepatic disease | |
Lymph node | 9 |
Lung | 3 |
Peritoneal | 3 |
Other | 1 |